www.fdanews.com/articles/113598-ucb-pharma-says-wilex-to-acquire-oncology-portfolio

UCB Pharma Says Wilex to Acquire Oncology Portfolio

January 9, 2009

Belgium pharmaceutical UCB Pharma said that it has signed a deal with Germany’s Wilex, under which Wilex will acquire the rights to develop UCB’s preclinical oncology portfolio.
Fox Business